Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing surveillance of long-term Inovelon tablets in Lennox-Gastaut syndrome
jRCT1080222123Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rufinamide in Lennox-Gastaut syndrome (LGS), sponsored by Eisai Co., Ltd. Started Jun 2013; status: recruiting.
02
Drugs
rufinamide
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on jRCT1080222123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222123.